EHC RSI Chart
Last 7 days
3.0%
Last 30 days
3.1%
Last 90 days
18.1%
Trailing 12 Months
38.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 5.0B | 0 | 0 | 0 |
2023 | 4.4B | 4.6B | 4.7B | 4.8B |
2022 | 4.1B | 4.2B | 4.3B | 4.3B |
2021 | 4.4B | 4.3B | 4.2B | 4.0B |
2020 | 4.7B | 4.6B | 4.6B | 4.6B |
2019 | 4.4B | 4.4B | 4.5B | 4.6B |
2018 | 4.0B | 4.1B | 4.2B | 4.3B |
2017 | 3.8B | 3.8B | 3.9B | 3.9B |
2016 | 3.3B | 3.5B | 3.6B | 3.7B |
2015 | 2.6B | 2.7B | 2.9B | 3.2B |
2014 | 2.3B | 2.3B | 2.4B | 2.4B |
2013 | 2.2B | 2.2B | 2.3B | 2.3B |
2012 | 2.1B | 2.1B | 2.1B | 2.2B |
2011 | 1.9B | 2.0B | 2.0B | 2.0B |
2010 | 1.8B | 1.8B | 1.7B | 1.9B |
2009 | 0 | 1.8B | 1.8B | 1.8B |
2008 | 0 | 0 | 0 | 1.8B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 06, 2024 | darby john patrick | sold | -1,220,740 | 83.94 | -14,543 | evp, gen counsel & secretary |
May 06, 2024 | darby john patrick | acquired | 422,620 | 29.06 | 14,543 | evp, gen counsel & secretary |
May 03, 2024 | carmichael greg d | bought | 167,460 | 83.73 | 2,000 | - |
May 02, 2024 | o'connor kevin j. | acquired | - | - | 1,978 | - |
May 02, 2024 | carmichael greg d | acquired | - | - | 1,978 | - |
May 02, 2024 | herman joan e | acquired | - | - | 1,978 | - |
May 02, 2024 | christie edward m iii | acquired | - | - | 1,978 | - |
May 02, 2024 | katz leslye g | acquired | - | - | 1,978 | - |
May 02, 2024 | reidy christopher r | acquired | - | - | 1,978 | - |
May 02, 2024 | maryland patricia anne | acquired | - | - | 1,978 | - |
Which funds bought or sold EHC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | Parallel Advisors, LLC | added | 54.28 | 34,770 | 73,001 | -% |
May 06, 2024 | DiNuzzo Private Wealth, Inc. | unchanged | - | 286 | 1,487 | -% |
May 06, 2024 | Envestnet Portfolio Solutions, Inc. | added | 10.63 | 142,758 | 529,326 | -% |
May 06, 2024 | TEXAS PERMANENT SCHOOL FUND CORP | added | 1.32 | 1,467,790 | 7,244,740 | 0.06% |
May 06, 2024 | SG Americas Securities, LLC | sold off | -100 | -1,568,000 | - | -% |
May 06, 2024 | Manchester Capital Management LLC | unchanged | - | 79.00 | 413 | -% |
May 06, 2024 | TEACHER RETIREMENT SYSTEM OF TEXAS | added | 0.82 | 798,000 | 4,015,000 | 0.03% |
May 06, 2024 | Quantbot Technologies LP | new | - | 1,592,390 | 1,592,390 | 0.09% |
May 06, 2024 | Jefferies Financial Group Inc. | sold off | -100 | -631,707 | - | -% |
May 06, 2024 | Candriam S.C.A. | added | 3.68 | 1,184,180 | 5,366,380 | 0.03% |
Unveiling Encompass Health Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Encompass Health Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 462.0B | 371.6B | 20.64 | 1.24 | ||||
CI | 98.5B | 206.0B | 25.56 | 0.48 | ||||
HCA | 82.4B | 66.7B | 15.06 | 1.23 | ||||
CVS | 70.0B | 360.9B | 9.55 | 0.19 | ||||
CNC | 40.5B | 155.5B | 14.81 | 0.26 | ||||
DVA | 12.1B | 12.3B | 14.8 | 0.98 | ||||
UHS | 11.7B | 14.3B | 16.37 | 0.82 | ||||
MID-CAP | ||||||||
CHE | 8.8B | 2.3B | 30.96 | 3.83 | ||||
ACHC | 6.3B | 3.0B | -553.66 | 2.09 | ||||
AMN | 2.3B | 3.8B | 10.82 | 0.6 | ||||
AMEH | 2.1B | 1.4B | 34.65 | 1.52 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.07 | 1.57 | ||||
BKD | 1.4B | 3.0B | -7.37 | 0.46 | ||||
BEAT | 54.0M | - | -3.69 | - | ||||
AMS | 19.6M | 21.3M | 36.7 | 0.92 |
Encompass Health Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 5.6% | 1,316 | 1,247 | 1,207 | 1,187 | 1,160 | 1,137 | 1,090 | 1,063 | 1,059 | 1,043 | 1,011 | 1,002 | 960 | 1,214 | 1,174 | 1,074 | 1,182 | 1,184 | 1,162 | 1,135 | 1,124 |
Costs and Expenses | 4.9% | 1,109 | 1,057 | 1,028 | 1,003 | 982 | 958 | 941 | 913 | 907 | 656 | 844 | 1,069 | 1,023 | 61.00 | 1,001 | 975 | 1,002 | 1,022 | 990 | 965 | 937 |
S&GA Expenses | -100.0% | - | 53.00 | 50.00 | 55.00 | 43.00 | 43.00 | 38.00 | 36.00 | 37.00 | 42.00 | 39.00 | 54.00 | 39.00 | 34.00 | 39.00 | 43.00 | 36.00 | 64.00 | 53.00 | 77.00 | 53.00 |
EBITDA Margin | 0.4% | 0.21* | 0.21* | 0.21* | 0.21* | 0.20* | 0.20* | 0.18* | 0.19* | 0.21* | 0.23* | 0.21* | 0.21* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 0.9% | 35.00 | 35.00 | 36.00 | 36.00 | 36.00 | 38.00 | 38.00 | 60.00 | 40.00 | 40.00 | 40.00 | 42.00 | 43.00 | 46.00 | 49.00 | 46.00 | 43.00 | 45.00 | 40.00 | 38.00 | 37.00 |
Income Taxes | 3.0% | 38.00 | 37.00 | 30.00 | 33.00 | 32.00 | 32.00 | 22.00 | 23.00 | 24.00 | 23.00 | 26.00 | 28.00 | 25.00 | 38.00 | 27.00 | 12.00 | 27.00 | 27.00 | 34.00 | 24.00 | 31.00 |
Earnings Before Taxes | 8.3% | 178 | 165 | 145 | 151 | 146 | 151 | 107 | 83.00 | 110 | 71.00 | 128 | 182 | 167 | 30.00 | 127 | 60.00 | 136 | 118 | 154 | 135 | 157 |
EBT Margin | 2.0% | 0.13* | 0.13* | 0.13* | 0.12* | 0.11* | 0.10* | 0.09* | 0.09* | 0.12* | 0.14* | 0.12* | 0.12* | - | - | - | - | - | - | - | - | - |
Net Income | 28.4% | 113 | 88.00 | 85.00 | 91.00 | 88.00 | 89.00 | 45.00 | 49.00 | 88.00 | 92.00 | 100 | 113 | 107 | 86.00 | 78.00 | 34.00 | 87.00 | 68.00 | 98.00 | 91.00 | 102 |
Net Income Margin | 3.7% | 0.08* | 0.07* | 0.08* | 0.07* | 0.06* | 0.06* | 0.06* | 0.08* | 0.10* | 0.10* | 0.10* | 0.09* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 18.8% | 239 | 201 | 69.00 | 90.00 | 131 | -17.70 | -79.20 | 132 | 106 | -68.50 | 58.00 | 142 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 2.1% | 6,231 | 6,102 | 5,964 | 5,861 | 5,747 | 5,637 | 5,476 | 7,082 | 6,944 | 6,865 | 6,722 | 6,613 | 6,542 | 6,446 | 6,611 | 6,503 | 6,138 | 6,081 | 6,387 | 5,812 | 5,584 |
Current Assets | 10.5% | 930 | 842 | 814 | 824 | 762 | 717 | 734 | 1,032 | 950 | 921 | 910 | 859 | 1,001 | 949 | 1,174 | 1,102 | 785 | 756 | 1,077 | 845 | 683 |
Cash Equivalents | 94.5% | 134 | 69.00 | 100 | 118 | 85.00 | 22.00 | 60.00 | 136 | 77.00 | 49.00 | 66.00 | 73.00 | 224 | 186 | 450 | 419 | 105 | 60.00 | 422 | 222 | 56.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,095 | 2,041 | 2,003 | 1,959 | 1,875 | 1,788 | 1,736 |
Goodwill | 0% | 1,281 | 1,281 | 1,281 | 1,271 | 8.00 | 1,263 | 1,247 | 2,457 | 2,457 | 1,237 | 2,418 | 2,412 | 2,319 | 1,228 | 2,319 | 2,319 | 2,312 | 1,219 | 2,305 | 2,112 | 2,112 |
Liabilities | 0.6% | 3,828 | 3,805 | 3,775 | 3,804 | 3,784 | 3,775 | 3,728 | 4,538 | 4,452 | 4,466 | 4,428 | 4,404 | 4,468 | 4,444 | 4,681 | 4,638 | 4,307 | 4,148 | 4,506 | 3,876 | 3,694 |
Current Liabilities | 3.6% | 680 | 656 | 639 | 655 | 592 | 576 | 605 | 835 | 755 | 749 | 794 | 805 | 812 | 717 | 683 | 664 | 586 | 721 | 1,109 | 753 | 768 |
Long Term Debt | -0.2% | 2,683 | 2,688 | 2,693 | 2,698 | 2,723 | 2,742 | 2,719 | 3,234 | 3,221 | 3,241 | 3,142 | 3,106 | 3,160 | 3,251 | 3,539 | 3,547 | 3,322 | 3,023 | 2,962 | 2,720 | 2,522 |
Shareholder's Equity | 43.4% | 2,362 | 1,648 | 1,560 | 2,018 | 1,926 | 1,310 | 1,710 | 2,501 | 2,448 | 2,357 | 2,261 | 2,176 | 2,043 | 1,970 | 1,896 | 1,831 | 1,797 | 1,693 | 1,671 | 1,584 | 1,617 |
Retained Earnings | -100.0% | - | 407 | - | - | - | 116 | - | - | - | 142 | - | - | - | -242 | - | - | - | -526 | - | - | - |
Additional Paid-In Capital | -100.0% | - | 1,787 | - | - | - | 1,730 | - | - | - | 2,290 | - | - | - | 2,327 | - | - | - | 2,370 | - | - | - |
Shares Outstanding | 0.3% | 100 | 100 | 100 | 100 | 99.00 | 99.00 | 99.00 | 99.00 | 99.00 | 99.00 | 99.00 | 99.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | 2.1% | 620 | 608 | 587 | 542 | 542 | 516 | 493 | 498 | 475 | 446 | 418 | 414 | 388 | 382 | 375 | 369 | 353 | 341 | 338 | 308 | 302 |
Float | - | - | - | - | 6,700 | - | - | - | 5,500 | - | - | - | 7,600 | - | - | - | 6,000 | - | - | - | 6,200 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 18.8% | 238,800 | 201,000 | 215,200 | 206,700 | 227,900 | 172,200 | 70,100 | 244,600 | 218,900 | 123,800 | 177,600 | 255,900 | 158,500 | 279,700 | 173,400 | 222,300 | 29,300 | 215,600 | 114,400 | 145,400 | 159,900 |
Share Based Compensation | -30.6% | 9,300 | 13,400 | 13,700 | 15,600 | 7,900 | 8,100 | 7,300 | 7,700 | 6,100 | 9,500 | 4,800 | 12,000 | 2,800 | 300 | 8,300 | 9,900 | 7,100 | 27,400 | 21,700 | 45,900 | 19,400 |
Cashflow From Investing | 37.7% | -129,700 | -208,100 | -162,200 | -128,500 | -104,000 | -206,400 | -174,300 | -123,200 | -123,100 | -220,700 | -124,000 | -226,000 | -95,600 | -142,700 | -89,700 | -92,100 | -83,000 | -145,700 | -320,100 | -100,100 | -91,500 |
Cashflow From Financing | -35.8% | -40,600 | -29,900 | -65,800 | -43,500 | -58,000 | -16,500 | -49,000 | -19,300 | -60,900 | 42,300 | -18,500 | -186,400 | -77,500 | -354,200 | -45,600 | 182,800 | 71,100 | -424,100 | 431,800 | 122,200 | -81,700 |
Dividend Payments | 6.7% | 15,900 | 14,900 | 15,000 | 14,900 | 15,600 | 14,900 | 27,800 | 27,800 | 28,500 | 27,700 | 27,600 | 27,800 | 29,100 | 27,500 | 27,600 | 27,700 | 29,000 | 27,400 | 26,400 | 26,600 | 28,300 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,200 | - | - | - | - | 2,100 | - | - |
Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Net operating revenues | $ 1,316.0 | $ 1,160.4 |
Operating expenses: | ||
Salaries and benefits | 711.6 | 629.0 |
Other operating expenses | 203.9 | 177.9 |
Occupancy costs | 14.0 | 13.8 |
Supplies | 58.5 | 53.8 |
General and administrative expenses | 50.2 | 43.4 |
Depreciation and amortization | 70.3 | 63.9 |
Total operating expenses | 1,108.5 | 981.8 |
Interest expense and amortization of debt discounts and fees | 35.2 | 36.4 |
Other income | (5.4) | (3.6) |
Equity in net income of nonconsolidated affiliates | (0.7) | (0.4) |
Income from continuing operations before income tax expense | 178.4 | 146.2 |
Provision for income tax expense | 38.3 | 31.9 |
Income from continuing operations | 140.1 | 114.3 |
Loss from discontinued operations, net of tax | (1.3) | (1.0) |
Net and comprehensive income | 138.8 | 113.3 |
Net and comprehensive income | 138.8 | 113.3 |
Less: Net and comprehensive income attributable to noncontrolling interests | (26.3) | (25.6) |
Less: Net and comprehensive income attributable to noncontrolling interests | (26.3) | (25.6) |
Net and comprehensive income attributable to Encompass Health | 112.5 | 87.7 |
Net and comprehensive income attributable to Encompass Health | $ 112.5 | $ 87.7 |
Weighted average common shares outstanding: | ||
Basic (in shares) | 99.8 | 99.4 |
Diluted (in shares) | 102.2 | 100.9 |
Basic earnings per share attributable to Encompass Health common shareholders: | ||
Continuing operations (in dollars per share) | $ 1.13 | $ 0.89 |
Discontinued operations (in dollars per share) | (0.01) | (0.01) |
Net income (in dollars per share) | 1.12 | 0.88 |
Diluted earnings per share attributable to Encompass Health common shareholders: | ||
Continuing operations (in dollars per share) | 1.11 | 0.88 |
Discontinued operations (in dollars per share) | (0.01) | (0.01) |
Net income (in dollars per share) | $ 1.10 | $ 0.87 |
Amounts attributable to Encompass Health common shareholders: | ||
Income from continuing operations | $ 113.8 | $ 88.7 |
Loss from discontinued operations, net of tax | (1.3) | (1.0) |
Net and comprehensive income attributable to Encompass Health | $ 112.5 | $ 87.7 |
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | ||
---|---|---|---|---|
Current assets: | ||||
Cash and cash equivalents | $ 134.4 | $ 69.1 | ||
Restricted cash | 38.3 | 35.1 | ||
Accounts receivable | 619.3 | 611.6 | ||
Other current assets | 137.8 | 126.0 | ||
Total current assets | 929.8 | 841.8 | ||
Property and equipment, net | 3,370.3 | 3,301.0 | ||
Operating lease right-of-use assets | 199.1 | 208.5 | ||
Goodwill | 1,281.3 | 1,281.3 | ||
Intangible assets, net | 272.2 | 278.2 | ||
Other long-term assets | 178.7 | 191.6 | ||
Total assets | [1] | 6,231.4 | 6,102.4 | |
Current liabilities: | ||||
Current portion of long-term debt | 25.6 | 24.8 | ||
Current operating lease liabilities | 25.4 | 24.1 | ||
Accounts payable | 166.1 | 170.0 | ||
Accrued expenses and other current liabilities | 463.2 | 437.5 | ||
Total current liabilities | 680.3 | 656.4 | ||
Long-term debt, net of current portion | 2,682.6 | 2,687.8 | ||
Long-term operating lease liabilities | 185.8 | 196.1 | ||
Deferred income tax liabilities | 93.5 | 87.0 | ||
Other long-term liabilities | 185.8 | 177.9 | ||
Total liabilities | 3,828.0 | 3,805.2 | ||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 41.1 | 42.0 | ||
Shareholders’ equity: | ||||
Encompass Health shareholders’ equity | 1,741.9 | 1,647.5 | ||
Noncontrolling interests | 620.4 | 607.7 | ||
Total shareholders’ equity | 2,362.3 | 2,255.2 | ||
Total liabilities and shareholders' equity | [1] | $ 6,231.4 | $ 6,102.4 | |
|
 | Mr. Mark J. Tarr |
---|---|
 | encompasshealth.com |
 | Healthcare Plans |
 | 36900 |